Key result
Cardiac surgery with mitral valve replacement successfully treated severe infective endocarditis occurring one month after MitraClip implantation in an 88-year-old high-risk patient.
Case Report (n=1)
No
Cardiac surgery can be a successful bail-out strategy for infective endocarditis following MitraClip implantation, even in patients with very high surgical risk.
Answers are grounded in this paper and cite their sources.
Surgical bailout may succeed for post-MitraClip endocarditis even at extreme risk; case report leaves open incidence, prevention, and generalizability.
AIMS: To report the first described case of a mitral valve infective endocarditis (IE) post MitraClip®. METHODS AND RESULTS: An 88-year-old patient at high surgical risk (log. EuroSCORE 30.4%) underwent a MitraClip procedure for severe eccentric organic mitral regurgitation (MR) due to prolapse with a flail leaflet of the P2 segment (flail gap 6 mm). After one month, the patient was readmitted to our department for fever and recurrence of shortness of breath. An echocardiogram demonstrated severe MR recurrence due to ulceration in the region of the posterior leaflet despite good insertion of both clips, and a large vegetation of 1513 mm within the clip region. Blood cultures were positive for staphylococcus aureus. The patient was treated by cardiac surgery with mitral valve replacement due to IE despite a very high logistic EuroSCORE of 56.8%. Histological and bacteriological analysis of the clip devices confirmed active IE. After cardiac surgery, transthoracic echocardiography showed no mitral regurgitation and a mean gradient across the mitral valve bioprosthesis of about 5 mmHg. The patient was discharged to a rehabilitation department 15 days after cardiac surgery. CONCLUSIONS: Surgical treatment as bail-out therapy for MR recurrence secondary to IE after MitraClip can be successfully carried out despite a high surgical risk.
No takes yet. Share an insight, caveat, or question.
Frerker et al. (2015) conducted a case report in Infective endocarditis after MitraClip implantation (n=1). Cardiac surgery (mitral valve replacement) was evaluated on Survival and successful treatment of infective endocarditis. Cardiac surgery with mitral valve replacement successfully treated severe infective endocarditis occurring one month after MitraClip implantation in an 88-year-old high-risk patient.
Synapse has enriched 10 related papers. Consider them for comparative context: